Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FYRQH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,174
Award facts
- Contract value 100% obligated
- $18,173.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,173.69 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills medical supply requirements for the Defense Logistics Agency across a broad spectrum of therapeutic domains. The company's federal contracting portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. This particular delivery order for RINVOQ ER, a rheumatoid arthritis treatment, exemplifies the company's role in providing essential pharmaceutical commodities to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. All of AmerisourceBergen's reviewed contract awards have been competitively awarded with firm fixed pricing, reflecting its capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DB25FYRQH?
SPE2DB25FYRQH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FYRQH worth?
The government has obligated $18,174 on SPE2DB25FYRQH.
Is contract SPE2DB25FYRQH an order under another contract?
Yes. SPE2DB25FYRQH is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYRQH competed?
The extent of competition for SPE2DB25FYRQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award